Table 1.
Definitions and diagnostic criteria for metabolic syndrome
| WHO (modified)* | NCEP-ATPIII † | IDF ‡ | JIS § | |
|---|---|---|---|---|
| Blood pressure | ≥ 140/90 mmHg or SAH treatment(//) | ≥ 130/85 mmHg | ≥ 130/85 mmHg or SAH treatment | ≥ 130/85 mmHg or SAH treatment |
| Anthropometrics | WHR (¶ ) ♂ > 0.9 and ♀ > 0.85and/or BMI (#) > 30 kg/m2 | WC(§§) ≥ 102 ♂ ≥ 88 ♀ | WC ≥ 94 ♂ ≥ 80 ♀ | WC ≥ 94 ♂ ≥ 80 ♀ |
| Glucose | DM.IGT (**) or Homa-1 IR (††) > 2.7 | ≥ 110 | ≥ 100 | ≥ 100 |
| TG | ≥ 150 ( ‡‡) | ≥ 150 | ≥ 150 | ≥ 150 |
| HDL-col | ♂ < 35 ♀ < 39 | ♂ < 40 ♀ < 50 | ♂ < 40 ♀ < 50 | ♂ < 40 ♀ < 50 |
| MS Criterion | DM, IGT or Homa-1 IR > 2.7 +2 other components | 3 or more components | WC plus 2 components | 3 or more components |
(*)
WHO: World Health Organization;
(†)NCEP-ATPIII-Third Report of the National Cholesterol Education Program; (‡)IDF-International Diabetes Federation; (§) JIS: Joint Interim Statement. ( //) SAH: Systemic Arterial Hypertension; (¶ )WHR: waist/hip ratio;(#)BMI: Body Mass Index;
(**)
IGT: Impaired glucose tolerance; (††) Homa1-IR: Homeostatic model assessment; (‡‡)Bothaltered TG orlow HDL-c constitute only one factorbyWHO; (§§)WC: waist circumference.